FrancophonIA/ELRC3.0 huggingface dataset:
English: The influenza virus strain in Pandemic influenza vaccine H5N1 AstraZeneca is (a) cold-adapted (ca); (b) temperature-sensitive (ts); and (c) attenuated (att).
Danish: Influenzavirusstammerne i Pandemisk influenzavaccine H5N1 AstraZenecaer (a) koldtadapterede (cold-adapted, ca); (b) temperaturfølsomme (temperature-sensitive, ts) og (c) svækkede (attenuated, att).
English: P/LAIV H5N1-primed subjects developed vigorous antibody responses to wild-type H5N1 virus upon subsequent exposure to the inactivated H5N1 vaccine, although such antibody responses were not detectable after the primary 2 doses in the majority of the subjects.
Danish: P/LAIV H5N1-primede forsøgspersoner udviklede kraftige antistofreaktioner på vildtype H5N1-virus ved efterfølgende eksponering for den inaktiverede H5N1-vaccine, selvom sådanne antistofreaktioner ikke kunne påvises efter de primære 2 doser hos størstedelen af forsøgspersonerne.
English: • It is recommended that Pandemic influenza vaccine H5N1 AstraZeneca is not given at the same time as influenza-specific antiviral medicines such as oseltamivir and zanamivir.
Danish: • Det anbefales, at Pandemisk influenzavaccine H5N1 AstraZeneca ikke gives på samme tidspunkt som influenzaspecifik antiviral medicin såsom oseltamivir og zanamivir, da vaccinen kan blive mindre effektiv.
English: Reassortant influenza virus (live attenuated) of the following strain:
Danish: Reassortant influenzavirus (levende svækket) af følgende stamme:
English: • if you have had any allergic reaction other than a sudden life-threatening allergic reaction to eggs, egg proteins, gentamicin, or gelatin or any of the other ingredients of this vaccine (listed in section 6 “Contents of the pack and other information”).
Danish: • hvis du tidligere har haft en allergisk reaktioner ud over en pludselig livstruende allergisk reaktion over for æg, æggeproteiner, gentamicin eller gelatine eller et af de øvrige indholdsstoffer i vaccinen (angivet i punkt 6).
English: Chronic conditions
Danish: Kroniske sygdomme
English: Twenty-one additional subjects received one dose of the vaccine virus at TCID50, with 19 of those subjects receiving a second dose 4-8 weeks later.
Danish: Yderligere 21 forsøgspersoner fik en dosis af vaccinevirussen på 10 TCID50, og 19 af disse forsøgspersoner fik en 2. dosis 4-8 uger senere.
English: Healthcare providers need to assess the benefits and potential risks of administering Pandemic influenza vaccine H5N1 AstraZeneca to these individuals.
Danish: Sundhedspersonalet skal vurdere fordele og potentielle risici ved administration af Pandemisk influenzavaccine H5N1 AstraZenecatil disse personer.
English: In study participants who received 2 doses in year 1 and placebo in year 2, efficacy in year 2 was 56.2% (95% CI: 30.5, 72.7) against matched strains and 44.8% (95% CI: 18.2, 62.9) against all strains regardless of match, respectively, in D153-P501, thus supporting the need for second-season revaccination.
Danish: Hos studiedeltagere (D153-P501), som fik 2 doser år 1 og placebo år 2, var effekten år 2 henholdsvis 56,2 % (95 % CI: 30,5-72,7) mod matchede stammer og 44,8 % (95 % CI: 18,2, 62,9) mod alle stammer uanset match, hvilket understøtter nødvendigheden af revaccination i 2. sæson.
English: Pandemic influenza vaccine H5N1 AstraZeneca will be administered under the supervision of a doctor, nurse or pharmacist.
Danish: Pandemisk influenzavaccine H5N1 AstraZeneca vil blive indgivet under overvågning af en læge eller sygeplejerske.
English: The active substance is: Reassortant influenza virus* (live attenuated) of the following strain**:
Danish: Aktivt stof: Reassortant influenzavirus* (levende svækket) af følgende stamme **:
English: Position the applicator With the patient in an upright position, place the tip just inside the nostril to ensure Pandemic influenza vaccine H5N1
Danish: Placering af applikatoren Mens patienten er i en opret stilling, placeres spidsen lige indenfor næseboret for at sikre, at Pandemisk influenzavaccine H5N1 AstraZenecaindgives i næsen.
English: There was no evidence of significant maternal adverse outcomes in 138 pregnant women who had a record of receiving the seasonal T/LAIV vaccine in a US-based health insurance claims database.
Danish: Ifølge en database med skadesanmeldelser til en sundhedsforsikring med base i USA var der ingen evidens for signifikante maternelle komplikationer hos 138 gravide kvinder, som tidligere havde modtaget den sæsonbetingede T/LAIV-influenza-vaccine.
English: Improved efficacy (95% CI) matched strains
Danish: Forbedret effekt (95 % CI) matchede stammer
English: Vaccine recipients under treatment with influenza antiviral agents should not receive Pandemic influenza vaccine H5N1 AstraZeneca until 48 hours after the cessation of influenza antiviral therapy.
Danish: Patienter i behandling med antivirale stoffer mod influenza bør ikke få Pandemisk influenzavaccine H5N1 AstraZenecatidligere end 48 timer efter ophør af den antivirale behandling af influenza.
English: For placebo recipients regardless of baseline serostatus, seroresponse rate was 6.3% on Days 15 and 29 and 14.5% on Day 57.
Danish: For placebo var seroresponseraterne 6,3 % på dag 15 og 29 og 14,5 % på dag 57 uanset serostatus ved baseline.
English: PACK SIZE OF 5 SINGLE-USE NASAL APPLICATORS
Danish: PAKNINGSSTØRRELSE PÅ 5 NASALAPPLIKATORER TIL ENGANGSBRUG
English: Pandemic influenza vaccine H5N1 AstraZeneca should not be used in infants below 12 months of age because of safety concerns regarding increased rates of hospitalisation and wheezing in this population (see section 4.8).
Danish: Pandemisk influenzavaccine H5N1 AstraZeneca bør ikke anvendes til børn under 12 måneder på grund af problemstillinger vedrørende sikkerheden med et øget antal indlæggelser og hvæsende vejrtrækning hos denne population (se pkt.
English: In clinical studies with adults who received Pandemic influenza vaccine H5N1 AstraZeneca, the most common side effects were headache and upper respiratory tract infection (inflammation of the nose, throat and sinuses).
Danish: I kliniske studier med voksne, som fik Pandemisk influenzavaccine H5N1 AstraZeneca, var de hyppigste bivirkninger hovedpine og infektion i de øvre luftveje (betændelse eller betændelseslignende reaktioner i næsen, halsen og bihulerne).
English: (See also How Pandemic influenza vaccine H5N1 AstraZeneca is given, in section 3).
Danish: (Se også Sådan skal Pandemisk influenzavaccine H5N1 AstraZeneca gives, i punkt 3).
English: In order to further corroborate the efficacy of Pandemic influenza vaccine H5N1 AstraZeneca, the MAH should conduct an observational effectiveness study in community dwelling children and adolescents from 12 months to less than 18 years of age against laboratory confirmed influenza during the next declared pandemic.
Danish: For yderligere at underbygge effekten af Pandemisk influenzavaccine H5N1 AstraZeneca skal indehaveren af markedsføringstilladelsen udføre et observerende studie på institutionaliserede børn og unge fra 12 måneder til under 18 år af effekten mod laboratoriebekræftet influenza under den næste erklærede pandemi.
English: • if you have previously had a serious allergic reaction (i.e. life-threatening) to eggs, egg proteins, gentamicin, or gelatin or any of the other ingredients of this vaccine (listed in section 6 “Contents of the pack and other information”).
Danish: • hvis du tidligere har haft en alvorlig allergisk reaktion (dvs. livstruende) over for æg, æggeproteiner, gentamicin eller gelatine eller et af de øvrige indholdsstoffer i denne vaccine
English: The MAH should conduct an observational prospective cohort safety study in a large sample of children and adolescents from 12 months to less than 18 years of age during the next declared pandemic.
Danish: Indehaveren af markedsføringstilladelsen skal udføre et prospektivt, observerende, kohorte-baseret sikkerhedsstudie på en stor gruppe af børn og unge fra 12 måneder til under 18 år under den næste erklærede pandemi.
English: The rate of hospitalisations was not increased in T/LAIV recipients 12 months and older and the rates for infants and toddlers 12-23 months of age were 3.2% T/LAIV versus 3.5% injectable influenza vaccine.
Danish: Hyppigheden af indlæggelser steg ikke hos modtagere af T/LAIV, der var 12 måneder og ældre; for spædbørn og småbørn i alderen 12-23 måneder var frekvensen 3,2 % for T/LAIV versus 3,5 % for influenzavaccine til injektion.
English: Very rare (may affect up to 1 in 1,000,000 people):
Danish: Meget sjælden (kan forekomme hos op til 1 ud af 1 000 000):
English: He or she will decide if Pandemic influenza vaccine H5N1 AstraZeneca is suitable for you.
Danish: Han eller hun vil beslutte, om Pandemisk influenzavaccine H5N1 AstraZenecaer passende for dig.
English: No data exist regarding the safety of intranasal administration of Pandemic influenza vaccine H5N1 AstraZeneca in children with unrepaired craniofacial malformations.
Danish: Der foreligger ingen data angående sikkerheden af intranasal administration af Pandemisk influenzavaccine H5N1 AstraZenecahos børn med ikke-opererede kraniofaciale misdannelser.
English: Antibody response developed rapidly in P/LAIV H5N1-primed subjects.
Danish: Antistofrespons udvikledes hurtigt hos P/LAIV H5N1-primede forsøgspersoner.
English: Efficacy (95% CI) all strains regardless of match
Danish: Effekt (95 % CI) alle stammer uanset match
English: Pandemic influenza vaccine H5N1 AstraZeneca is not indicated for use in infants younger than 12 months of age (see section 4.2).
Danish: Pandemisk influenzavaccine H5N1 AstraZenecaer ikke indiceret til småbørn under 12 måneder (se pkt.
English: Talk to your doctor, nurse or pharmacist before vaccination:
Danish: Advarsler og forsigtighedsregler Kontakt lægen, apotekspersonalet eller sundhedspersonalet før vaccination:
English: In clinical study CIR 217, the safety, infectivity and immunogenicity of a live attenuated vaccine derived from A/Vietnam/1203/2004 (H5N1) influenza isolate were evaluated in 21 subjects who received one 10
Danish: I det kliniske studie CIR 217 blev sikkerhed, smitsomhed og immunogenicitet af en levende svækket vaccine afledt af A/Vietnam/1203/2004 (H5N1)-influenzaisolat undersøgt hos 21 forsøgspersoner, som fik en dosis på 10
English: 12 to 35 M
Danish: 12 til 35 mdr
English: Dibasic potassium phosphate Monobasic potassium phosphate Gelatin (porcine, Type A) Arginine hydrochloride Monosodium glutamate monohydrate Water for injections
Danish: Dikaliumphosphat Kaliumdihydrogenphosphat Gelatine (porcin, Type A) Argininhydrochlorid Mononatriumglutamatmonohydrat Vand til injektionsvæsker
English: Based upon the potential for influenza antiviral agents to reduce the effectiveness of Pandemic influenza vaccine H5N1 AstraZeneca, it is recommended not to administer the vaccine until 48 hours after the cessation of influenza antiviral therapy.
Danish: Baseret på muligheden for, at antivirale stoffer mod influenza potentielt kan reducere virkningen af Pandemisk influenzavaccine H5N1 AstraZeneca, frarådes det at give vaccinen i de første 48 timer efter ophør af antiviral behandling af influenza.
English: • Do not use Pandemic influenza vaccine H5N1 AstraZeneca if the expiry date has passed or if the sprayer appears damaged, for example, if the plunger is loose or displaced from the sprayer or if there are any signs of leakage.
Danish: • Pandemisk influenzavaccine H5N1 AstraZenecamå ikke anvendes, hvis udløbsdatoen er overskredet, eller hvis spraydelen virker beskadiget, for eksempel hvis stemplet er løst eller ikke sidder i spraydelen, eller hvis der er tegn på lækage.
English: In clinical study CIR 239, the safety, infectivity, and immunogenicity of a live attenuated vaccine derived from A/Hong Kong/213/2003 (H5N1) influenza isolate were evaluated in 17 subjects who received one dose of 10
Danish: I det kliniske studie CIR 239 blev sikkerhed, smitsomhed og immunogenicitet af en levende svækket vaccine afledt af A/Hong Kong/213/2003 (H5N1)-influenzaisolat undersøgt hos 17 forsøgspersoner, som fik en dosis på 10
English: SINGLE-USE NASAL APPLICATOR
Danish: NASALAPPLIKATOR TIL ENGANGSBRUG
English: In order to define the shelf life of Pandemic influenza vaccine H5N1 AstraZeneca on a strain-specific basis, the MAH should generate strain-specific stability data for the actual pandemic strain.
Danish: For at definere holdbarheden af Pandemisk influenzavaccine H5N1 AstraZeneca på et stammespecifik grundlag skal indehaveren af markedsføringstilladelsen generere stammespecifikke stabilitetsdata for den aktuelle pandemiske stamme.
English: You can breathe normally while you are given Pandemic influenza vaccine H5N1 AstraZeneca.
Danish: Du kan trække vejret normalt, mens du får Pandemisk influenzavaccine H5N1 AstraZeneca.
English: • Do not use Pandemic influenza vaccine H5N1 AstraZeneca if the expiry date has passed or the sprayer appears damaged, for example, if the plunger is loose or displaced from the sprayer or if there are any signs of leakage.
Danish: • Pandemisk influenzavaccine H5N1 AstraZenecamå ikke anvendes, hvis udløbsdatoen er overskredet eller hvis spraydelen virker beskadiget, for eksempel hvis stemplet er løst eller ikke isat spraydelen eller hvis der er tegn på lækage.
English: Healthcare providers need to assess the benefit and potential risks of administering Pandemic influenza vaccine H5N1 AstraZeneca to pregnant women.
Danish: Sundhedspersonalet skal vurdere fordele og potentielle risici ved at administrere Pandemisk influenzavaccine H5N1 AstraZenecatil gravide kvinder.
English: In the same study, an increased rate of wheezing through 42 days was observed in infants and toddlers 6-23 months of age (5.9% T/LAIV versus 3.8% injectable influenza vaccine).
Danish: Hvæsende vejrtrækning hos børn under 24 måneder I det samme studie blev der observeret en øget frekvens af hvæsende vejrtrækning i en periode på 42 dage hos spædbørn og småbørn i alderen 6-23 måneder (5,9 % med T/LAIV versus 3,8 % med influenzavaccine til vaccination).
English: Efficacy (95% CI) matched strains
Danish: Effekt (95 % CI) matchede stammer
English: There are no data available on the use of Pandemic influenza vaccine H5N1 AstraZeneca in pregnant women.
Danish: Der er ingen tilgængelige data fra anvendelse af Pandemisk influenzavaccine H5N1 AstraZenecatil gravide kvinder.
English: Pandemic influenza vaccine H5N1 AstraZeneca is a vaccine to prevent influenza (flu) in an officially declared pandemic.
Danish: Pandemisk influenzavaccine H5N1 AstraZenecaer en vaccine til forebyggelse af influenza under en officielt erklæret pandemi (verdensomspændende epidemi).
English: Pandemic influenza vaccine H5N1 AstraZeneca should be used in accordance with official guidance.
Danish: Pandemisk influenzavaccine H5N1 AstraZeneca skal anvendes i overensstemmelse med officielle retningslinjer.
English: • Pandemic influenza vaccine H5N1 AstraZeneca has no or negligible influence on the ability to drive and use machines.
Danish: • Pandemisk influenzavaccine H5N1 AstraZenecapåvirker ikke eller kun i ubetydelig grad evnen til at køre motorkøretøj og bruge maskiner.
English: Prophylaxis of influenza in an officially declared pandemic situation in children and adolescents from 12 months to less than 18 years of age.
Danish: Influenzaprofylakse til børn og unge fra 12 måneder og op til 18 år i en officielt erklæret pandemi.
English: Excipients: sucrose, dibasic potassium phosphate, monobasic potassium phosphate, gelatin (porcine, Type A), arginine hydrochloride, monosodium glutamate monohydrate, water for injections.
Danish: Hjælpestoffer: saccharose, dibasisk kaliumphosphat, monobasisk kaliumphosphat, gelatine (porcin, Type A), argininhydrochlorid, mononatriumglutamatmonohydrat, vand til injektionsvæsker.
English: Pandemic influenza vaccine H5N1 AstraZeneca has no or negligible influence on the ability to drive and use machines.
Danish: Pandemisk influenzavaccine H5N1 AstraZenecapåvirker ikke eller kun i ubetydelig grad evnen til at føre motorkøretøj og betjene maskiner.
English: Caution is needed when administering this vaccine to individuals with a known hypersensitivity (other than anaphylactic reaction) to the active substance, or to any of the excipients listed in section 6.1, or to trace residues (gentamicin, eggs or egg proteins, ovalbumin).
Danish: Der skal udvises forsigtighed ved administration af denne vaccine til personer med kendt overfølsomhed (ud over anafylaktisk reaktion) over for det aktive stof eller over for et eller flere af hjælpestofferne nævnt i pkt.
English: The other ingredients are sucrose, dibasic potassium phosphate, monobasic potassium phosphate, gelatin (porcine, Type A), arginine hydrochloride, monosodium glutamate monohydrate and water for injections.
Danish: Øvrige indholdsstoffer: Saccharose, dikaliumphosphat, kaliumdihydrogenphosphat, gelatine (porcin, Type A), argininhydrochlorid, mononatriumglutamatmonohydrat og vand til injektionsvæsker.
English: Pandemic influenza vaccine H5N1 AstraZeneca Pandemic influenza vaccine
Danish: Pandemisk influenzavaccine H5N1 AstraZeneca Pandemisk influenzavaccine
English: History of an anaphylactic (i.e. life-threatening) reaction to the active substance or to any of the excipients listed in section 6.1 (e.g. gelatin), or to gentamicin (a possible trace residue), to eggs or to egg proteins (e.g. ovalbumin).
Danish: 6.1 (fx gelatine), eller over for gentamicin (et muligt reststof), over for æg eller over for æggeproteiner (fx ovalbumin).
English: 6 to 35 M
Danish: 6 til 35 mdr
English: No data exist regarding the possible effects of Pandemic influenza vaccine H5N1 AstraZeneca on male and female fertility.
Danish: Der eksisterer ingen data angående de mulige virkninger af Pandemisk influenzavaccine H5N1 AstraZenecapå hanlig og hunlig fertilitet.
English: • Refer to the Pandemic influenza vaccine H5N1 AstraZeneca administration diagram (Figure 1) for step-by-step administration instructions.
Danish: • Se administrationsdiagrammet (figur 1) for trinvis instruktion i administration.
English: If any of these apply, tell your doctor, nurse or pharmacist.
Danish: Hvis noget af dette gælder for dig, skal ud fortælle det til lægen, sundhedspersonalet eller apotekspersonalet.
English: 11 to 24 M 1,150 2002-2003
Danish: 11 til 24 mdr
English: It is not known whether Pandemic influenza vaccine H5N1 AstraZeneca is excreted in human milk.
Danish: Det er ukendt, om Pandemisk influenzavaccine H5N1 AstraZenecaudskilles i human mælk.
English: After 1 or 2 doses of 10 TCID50 vaccine, HAI and IgA seroresponses were each detected in 10% and 52% of subjects and nasal IgA responses were detected in 19% of subjects.
Danish: TCID50-vaccine blev HAI-respons og IgA-serorespons påvist hos henholdsvis 10 % og 52 % af forsøgspersonerne, og nasalt IgA-serorespons blev påvist hos 19 % af forsøgspersonerne.
English: Pandemic influenza vaccine H5N1 AstraZeneca vaccine virus is grown in chicken eggs.
Danish: Virus i Pandemisk influenzavaccine H5N1 AstraZenecaer dyrket i hønseæg.
English: Study number
Danish: Studie nr.
English: • Pandemic influenza vaccine H5N1 AstraZeneca is administered as a divided dose in both nostrils as described below.
Danish: • Pandemisk influenzavaccine H5N1 AstraZenecaadministreres som en delt dosis i begge næsebor som beskrevet nedenfor.
English: Pandemic influenza vaccine H5N1 AstraZeneca must not be injected.
Danish: Pandemisk influenzavaccine H5N1 AstraZeneca må ikke injiceres.
English: In clinical studies, the safety profile of Pandemic influenza vaccine H5N1 AstraZeneca was comparable to the safety profile of the seasonal vaccines T/LAIV and Fluenz Tetra (see section 5.1 for more information).
Danish: AstraZenecasammenlignelig med sikkerhedsprofilen for de sæsonbetingede influenzavacciner T/LAIV og Fluenz Tetra (se pkt.
English: Other possible side effects of Pandemic influenza vaccine H5N1 AstraZeneca:
Danish: Andre bivirkninger ved Pandemisk influenzavaccine H5N1 AstraZeneca:
English: What you need to know before you are given Pandemic influenza vaccine H5N1 AstraZeneca
Danish: Det skal du vide, før du får Pandemisk influenzavaccine H5N1 AstraZeneca
English: Figure 1 Pandemic influenza vaccine H5N1 AstraZeneca Administration
Danish: Figur 1 Administration af Pandemisk influenzavaccine H5N1 AstraZeneca
English: Pandemic influenza vaccine H5N1 AstraZeneca is administered as a divided dose in both nostrils.
Danish: Pandemisk influenzavaccine H5N1 AstraZeneca administreres som en delt dosis i begge næsebor.
English: For administration in the other nostril, pinch and remove the dose-divider clip from plunger.
Danish: Fjern clipsen til dosisopdeling Klem clipsen til dosisopdeling sammen og fjern den fra stemplet, så vaccinen kan indgives i det andet næsebor.
English: Region Age range
Danish: Region Aldersinterval
English: You should not be given Pandemic influenza vaccine H5N1 AstraZeneca:
Danish: Du må ikke få Pandemisk influenzavaccine H5N1 AstraZeneca:
English: Pandemic influenza vaccine H5N1 AstraZeneca is similar to Fluenz Tetra (a nasal influenza vaccine containing four strains), except Pandemic influenza vaccine H5N1 AstraZeneca provides protection against a single influenza strain in an officially declared pandemic.
Danish: Pandemisk influenzavaccine H5N1 AstraZenecasvarer til Fluenz Tetra (en influenzavaccine til brug i næsen, der indeholder fire virus-stammer) bortset fra, at Pandemisk influenzavaccine H5N1
English: Pandemic influenza vaccine H5N1 AstraZeneca is for nasal use only.
Danish: Pandemisk influenzavaccine H5N1 AstraZeneca er kun til nasal anvendelse.
English: • Pandemic influenza vaccine H5N1 AstraZeneca is administered as a divided dose in both nostrils.
Danish: • Pandemisk influenzavaccine H5N1 AstraZenecaadministreres som en delt dosis i begge næsebor.
English: • Pandemic influenza vaccine H5N1 AstraZeneca is not recommended for breast-feeding women.
Danish: • Pandemisk influenzavaccine H5N1 AstraZenecafrarådes til ammende kvinder.
English: Pandemic influenza vaccine H5N1 AstraZeneca IS FOR NASAL USE ONLY.
Danish: Pandemisk influenzavaccine H5N1 AstraZenecaER KUN TIL NASAL ANVENDELSE.
English: What Pandemic influenza vaccine H5N1 AstraZeneca is and what it is used for What you need to know before you are given Pandemic influenza vaccine H5N1 AstraZeneca How Pandemic influenza vaccine H5N1 AstraZeneca is given Possible side effects
Danish: Det skal du vide, før du får Pandemisk influenzavaccine H5N1 AstraZeneca Sådan skal Pandemisk influenzavaccine H5N1 AstraZenecagives Bivirkninger
English: How Pandemic influenza vaccine H5N1 AstraZeneca is given
Danish: Sådan skal Pandemisk influenzavaccine H5N1 AstraZeneca gives
English: Pandemic influenza vaccine H5N1 AstraZeneca nasal spray, suspension Pandemic influenza vaccine (H5N1) (live attenuated, nasal)
Danish: Pandemisk influenzavaccine H5N1 AstraZeneca næsespray, suspension Pandemisk influenzavaccine (H5N1) (levende svækket, nasal)
English: Pandemic influenza vaccine H5N1 AstraZeneca must only be used as a nasal spray.
Danish: Pandemisk influenzavaccine H5N1 AstraZenecamå kun anvendes som næsespray.
English: Pandemic influenza vaccine H5N1 AstraZeneca, nasal spray suspension Pandemic influenza vaccine (H5N1) (live attenuated, nasal)
Danish: Pandemisk influenzavaccine H5N1 AstraZeneca, næsespray, suspension Pandemisk influenzavaccine (H5N1) (levende svækket, nasal)
English: What Pandemic influenza vaccine H5N1 AstraZeneca contains
Danish: Pandemisk influenzavaccine H5N1 AstraZeneca indeholder:
English: Pandemic influenza vaccine H5N1 AstraZeneca nasal spray, suspension Pandemic influenza vaccine (live attenuated, nasal)
Danish: Pandemisk influenzavaccine H5N1 AstraZenecanæsespray, suspension Pandemisk influenzavaccine (levende svækket, nasal)
English: Pandemic influenza vaccine H5N1 AstraZeneca will be given as a spray in each nostril.
Danish: Pandemisk influenzavaccine H5N1 AstraZenecagives som spray i begge næsebor.
English: Peak incidence of vaccine virus recovery occurred 1-2 days post-vaccination in clinical studies with Pandemic influenza vaccine H5N1 AstraZeneca.
Danish: I kliniske studier med Pandemisk influenzavaccine H5N1 AstraZenecaforekom den højeste udskillelse af vaccinevirus 1-2 dage efter vaccinationen.
English: How Pandemic influenza vaccine H5N1 AstraZeneca works
Danish: Sådan virker Pandemisk influenzavaccine H5N1 AstraZeneca